Patents Examined by Christina Marchetti Brad
  • Patent number: 7465703
    Abstract: The present invention relates to methods and kits useful for guiding the administration of a therapeutic agent in a subject afflicted with, or believed to be afflicted with osteoporosis.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: December 16, 2008
    Assignee: Scantibodies Laboratory, Inc.
    Inventor: Thomas L. Cantor
  • Patent number: 7429560
    Abstract: Compositions and methods for treating neural pathologies are provided. In particular, compositions and methods for treating neural pathologies including axonal degeneration are provided. The compositions include peptide ?-ketomides optionally in combination with a second therapeutic agent. Another aspect of the invention provides compositions and methods for treating hyperproliferative disorders. Exemplary compositions for treating hyperproliferative disorders include an anti-proliferative agent such as paclitaxel, in combination with a calpain inhibitor such as AK295.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: September 30, 2008
    Assignees: Georgia Tech Research Corporation, Emory University
    Inventors: James C. Powers, Jonathan D. Glass
  • Patent number: 7413877
    Abstract: The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 19, 2008
    Assignee: Genencor International, Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell